27 February 2025 Former Latham & Watkins global vice chair joins the firm as co-chair of its technology transactions practice ...
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...
Concerns over misuse, side effects and counterfeits are tightening controls on the blockbuster treatments, says Iona ...
A game-changer for UPC tech disputes ...
Former Latham & Watkins global vice chair joins the firm as co-chair of its technology transactions practice | New partner ...
Delaware federal judge reverses jury verdict in CareDx’s favour | Natera’s patents covering organ transplant testing ...
The company’s nine-country ban against a Chinese rival saw the court adopt a broad interpretation of means-plus-function ...
British pharma giant says that a Federal Circuit decision could stifle competition by lowering the bar for proving patent infringement | Earlier ruling ‘nullifies a statutory mechanism for expediting ...
Market leader settles patent disputes with generic drug makers, blocking the release of versions of two key products | More than 80% of HIV patients in the US use Gilead’s treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback